Maravai LifeSciences Holdings SG&A Expense (Quarterly) Analysis

Maravai LifeSciences Holdings Inc (MRVI)

7.305 -0.30 (-3.88%) USD | NASDAQ | Apr 19, 16:00

7.30 0.00 (0.00%) After-Hours: 19:23

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	38.48M
September 30, 2023	38.86M
June 30, 2023	35.38M
March 31, 2023	38.67M
December 31, 2022	37.20M
September 30, 2022	30.80M
June 30, 2022	28.06M
March 31, 2022	33.20M
December 31, 2021	25.58M

Date	Value
September 30, 2021	26.51M
June 30, 2021	24.50M
March 31, 2021	23.47M
December 31, 2020	41.62M
September 30, 2020	20.51M
June 30, 2020	15.99M
March 31, 2020	16.13M
December 31, 2019	15.78M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

15.78M

Minimum

Dec 2019

41.62M

Maximum

Dec 2020

28.87M

Average

28.06M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks